Cargando…

COVID-19 vaccine equity in the Americas

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785092/
https://www.ncbi.nlm.nih.gov/pubmed/35086649
http://dx.doi.org/10.1016/j.ebiom.2022.103849
_version_ 1784638890115596288
collection PubMed
description
format Online
Article
Text
id pubmed-8785092
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87850922022-01-24 COVID-19 vaccine equity in the Americas EBioMedicine Editorial Elsevier 2022-01-24 /pmc/articles/PMC8785092/ /pubmed/35086649 http://dx.doi.org/10.1016/j.ebiom.2022.103849 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
COVID-19 vaccine equity in the Americas
title COVID-19 vaccine equity in the Americas
title_full COVID-19 vaccine equity in the Americas
title_fullStr COVID-19 vaccine equity in the Americas
title_full_unstemmed COVID-19 vaccine equity in the Americas
title_short COVID-19 vaccine equity in the Americas
title_sort covid-19 vaccine equity in the americas
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785092/
https://www.ncbi.nlm.nih.gov/pubmed/35086649
http://dx.doi.org/10.1016/j.ebiom.2022.103849